Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 8,800 |
| Receivables | 0 | 230 |
| Other current assets | 0 | 230 |
| TOTAL | $0 | $9,260 |
| Non-Current Assets | ||
| PPE Net | N/A | 3,270 |
| Other Non-Current Assets | 0 | 2,830 |
| TOTAL | $N/A | $6,100 |
| Total Assets | $0 | $14,180 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 1,250 |
| Accounts payable and accrued liabilities | 0 | 930 |
| Accrued Expenses | 0 | 1,120 |
| Other current liabilities | 0 | 850 |
| TOTAL | $0 | $4,170 |
| Non-Current Liabilities | ||
| Long Term Debt | 0 | 2,940 |
| Other Non-Current Liabilities | 0 | 1,480 |
| TOTAL | $N/A | $9,550 |
| Total Liabilities | $0 | $13,740 |
| Shareholders' Equity | ||
| Common Shares | 0 | 1 |
| Retained earnings | 0 | -43,880 |
| Other shareholders' equity | 0 | 44,309 |
| TOTAL | $0 | $430 |
| Total Liabilities And Equity | $0 | $14,170 |